Officer sold ~$3.16M of Vertex Pharmaceuticals
Scheduled in advanceLoading…
Traded Dec 3, 2025 · Filed Dec 5, 2025
Vertex Pharmaceuticals's Executive Chairman sold $2.65M of Vertex Pharmaceuticals shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,645,059
Shares × reported transaction price
30 days after results of Nov 3, 2025, 71 days before results of Feb 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $463.13 on Dec 3, 2025, 26% above its 52-week low and 10% below its high, after a 9% rise over the previous 30 trading days
52-week range $366.54 (Aug 8, 2025) to $513.76 (Mar 17, 2025), 66% of the way up, from 250 adjusted closes. 30 trading days earlier: $426.27 on Oct 21, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.1% | -0.4% | +3.5% |
| 30 days | +9.5% | +0.9% | +8.7% |
| 90 days | +4.3% | -0.8% | +5.0% |
| 180 days | +0.2% | +8.1% | -7.9% |
Past results only. Not a forecast.
Officer sold ~$3.16M of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$3.23M of Vertex Pharmaceuticals
Scheduled in advanceOfficer sold ~$2.02M of Vertex Pharmaceuticals
Scheduled in advance
